동물 모델 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Animal Model Market size is expected to reach USD 7.08 Billion in 2034 from USD 3.24 Billion (2025) growing at a CAGR of 9.07% during 2026-2034.

The Global Animal Model Market has witnessed steady growth due to increasing research in drug development, disease studies, and biotechnology. Animal models play a critical role in preclinical testing and understanding complex biological processes. Rising investments in pharmaceutical R&D and the growing prevalence of chronic diseases have significantly supported market expansion.

Growth drivers include advancements in genetic engineering, increasing demand for personalized medicine, and expanding biomedical research initiatives. The development of transgenic and humanized animal models has enhanced research accuracy and efficiency. Government and academic funding for life sciences research further strengthens market growth.

In the future, the market is expected to grow alongside innovation in biotechnology and precision medicine. Ethical considerations and regulatory frameworks will continue shaping research practices. Emerging alternatives such as organ-on-chip technologies may complement, but not fully replace, animal models in the near term.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application Scope

• Cancer
• Immunological Disease
• Infectious Disease
• Others

By Animal Type Scope

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

COMPANIES PROFILED

• Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences Inc, Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, Biocytogen, BioSpherix Ltd, Animal M

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL MODEL MARKET: BY APPLICATION SCOPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application Scope
• 4.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL MODEL MARKET: BY ANIMAL TYPE SCOPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type Scope
• 5.2. Mice Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Guinea Pigs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Rabbits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hamsters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL MODEL MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL MODEL MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application Scope
  • 7.2.2 By Animal Type Scope
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application Scope
  • 7.3.2 By Animal Type Scope
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application Scope
  • 7.4.2 By Animal Type Scope
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application Scope
  • 7.5.2 By Animal Type Scope
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application Scope
  • 7.6.2 By Animal Type Scope
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANIMAL MODEL INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories
  • 9.2.2 The Jackson Laboratory
  • 9.2.3 GenOway
  • 9.2.4 Taconic Biosciences Inc
  • 9.2.5 Janvier Labs
  • 9.2.6 Harbour BioMed
  • 9.2.7 Crown Bioscience
  • 9.2.8 Inotiv
  • 9.2.9 Biocytogen
  • 9.2.10 BioSpherix Ltd
  • 9.2.11 Animal M